NASDAQ:FTRE Fortrea Q3 2026 Earnings Date & Estimates $20.84 +0.47 (+2.31%) Closing price 10/9/2026 04:00 PM EasternExtended Trading$21.28 +0.44 (+2.11%) As of 10/9/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Fortrea is scheduled to report Q3 2026 earnings on Thursday, October 29, 2026, before market opens. The conference call is scheduled for 8:00 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateOctober 29, 2026TimeBefore Market OpensConference Call8:00 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Fortrea in Q3 2026Fortrea is expected to post earnings of $0.2163 per share on revenue of $671.57 million. In the same quarter a year earlier Fortrea reported $0.12 per share on revenue of $701.30 million. Fortrea last reported on July 29, 2026, posting $0.23 per share and beating the $0.1804 consensus estimate. Fortrea has beaten the consensus EPS estimate in 4 of its last 8 quarters.Consensus EstimatesConsensus EPS$0.2163Expected Revenue$671.57 millionPrior-Year EPS$0.12Prior-Year Revenue$701.30 millionExpected EPS Growth+80.3%Expected Revenue Growth-4.2%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS$0.23 (Beat by +$0.0496)Last Quarter Revenue$678.20 millionEPS Beat Rate4 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Fortrea Q3 2026 Earnings FAQ When does Fortrea report Q3 2026 earnings? Fortrea (NASDAQ:FTRE) is scheduled to report Q3 2026 earnings on Thursday, October 29, 2026, before market opens. What time is Fortrea's Q3 2026 earnings call? Fortrea's Q3 2026 earnings conference call is scheduled for Thursday, October 29, 2026 at 8:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Fortrea? Analysts expect Fortrea to post earnings of $0.2163 per share for Q3 2026. How much revenue is Fortrea expected to report? The consensus revenue estimate for Fortrea is $671.57 million for Q3 2026. Fortrea Earnings HeadlinesFortrea (NASDAQ:FTRE) Stock Rating Upgraded by Wall Street ZenOctober 10 at 1:13 AM | americanbankingnews.comBarclays Upgrades Fortrea Holdings to Overweight From EqualweightOctober 6, 2026 | marketscreener.comMDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.October 11 at 1:00 AM | Stansberry Research (Ad)Fortrea (NASDAQ:FTRE) Hits New 52-Week High - Here's What HappenedOctober 6, 2026 | americanbankingnews.comFortrea Announces Date for Third Quarter 2026 Financial Results and Conference CallOctober 5, 2026 | globenewswire.comContrasting Bullfrog AI (NASDAQ:BFRG) and Fortrea (NASDAQ:FTRE)October 2, 2026 | americanbankingnews.comSee More Fortrea Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Fortrea? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fortrea and other key companies, straight to your email. Email Address About FortreaFortrea (NASDAQ:FTRE) is a global contract research organization (CRO) that provides services to pharmaceutical, biotechnology and medical device companies. The company supports the development and commercialization of healthcare products across a range of therapeutic areas. Its services include clinical trial management, study design, patient recruitment and engagement, data management, biostatistics, regulatory support, medical affairs and post-approval services. Fortrea also provides technology-enabled and decentralized clinical trial solutions intended to help sponsors conduct research across traditional and remote settings. Fortrea serves customers internationally, with operations and clinical trial capabilities spanning North America, Europe, Asia-Pacific and other global markets. The company was established in 2023 following the separation of Labcorp’s clinical development business and is headquartered in Durham, North Carolina.View Fortrea ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/05 - 10/09Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes NextDelta Air Lines Faces a Fuel Crisis—But There's a Silver LiningPalantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
